RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Looking further, I see Dr. Manuso presented at the 'Biotech Showcase' last Monday, Jan 9, which coincided with the stock moving up on higher volume. Looks like he discussed the fuller data from the Dronabinol Phase 2, and the press release also says RSPI will have a meeting with the FDA in "mid-year 2017 for an end of Phase 2 meeting at which the Company plans to obtain guidance for a Phase 3 clinical protocol that will enable the Company to bring dronabinol to market for the treatment of OSA. The Company will request a Special Protocol Assessment to clearly define a path to approval of a new drug application (“NDA”) by the FDA, and will seek fast-track and breakthrough designations for dronabinol in the treatment of OSA."


http://respirerx.com/respirerx-pharmaceuticals-inc-to-present-at-9th-annual-biotech-showcase-2017/



I'll check out the newest slide deck and see if I can listen to the archived webcast. Sorry for being asleep at the switch, guess I was preoccupied with other things (booze and women, I wish, lol). Looks like things could be looking up for ole RSPI.

Also there was a financing related SEC filing last Friday, Jan 13, so will check it out also -


https://www.sec.gov/Archives/edgar/data/849636/000084963617000001/xslFormDX01/primary_doc.xml